Clorox Co (CLX) Shares Bought by Piedmont Investment Advisors Inc.

Piedmont Investment Advisors Inc. grew its holdings in Clorox Co (NYSE:CLX) by 6.4% in the fourth quarter, HoldingsChannel reports. The firm owned 9,973 shares of the company’s stock after purchasing an additional 597 shares during the period. Piedmont Investment Advisors Inc.’s holdings in Clorox were worth $1,537,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Visionary Asset Management Inc. acquired a new position in shares of Clorox in the fourth quarter worth $225,000. Freestone Capital Holdings LLC increased its stake in shares of Clorox by 33.1% in the third quarter. Freestone Capital Holdings LLC now owns 2,074 shares of the company’s stock worth $312,000 after acquiring an additional 516 shares during the last quarter. Nuance Investments LLC increased its stake in shares of Clorox by 10.6% in the third quarter. Nuance Investments LLC now owns 42,291 shares of the company’s stock worth $6,355,000 after acquiring an additional 4,050 shares during the last quarter. Captrust Financial Advisors increased its stake in shares of Clorox by 1,011.2% in the third quarter. Captrust Financial Advisors now owns 6,856 shares of the company’s stock worth $1,031,000 after acquiring an additional 6,239 shares during the last quarter. Finally, JGP Wealth Management LLC increased its stake in shares of Clorox by 1.1% in the third quarter. JGP Wealth Management LLC now owns 16,484 shares of the company’s stock worth $2,479,000 after acquiring an additional 180 shares during the last quarter. Institutional investors own 77.90% of the company’s stock.

CLX has been the topic of a number of research reports. Citigroup upped their price target on shares of Clorox from $153.00 to $169.00 and gave the stock a “hold” rating in a research note on Tuesday, November 20th. Wells Fargo & Co reissued a “hold” rating and set a $157.00 target price on shares of Clorox in a research report on Monday, February 4th. Barclays set a $138.00 target price on shares of Clorox and gave the stock a “hold” rating in a research report on Thursday, November 1st. Zacks Investment Research downgraded shares of Clorox from a “hold” rating to a “sell” rating in a research report on Monday, December 31st. Finally, Deutsche Bank increased their target price on shares of Clorox from $123.00 to $124.00 and gave the stock a “sell” rating in a research report on Thursday, November 1st. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $149.08.

In other news, CEO Benno O. Dorer sold 152,449 shares of the firm’s stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $164.83, for a total value of $25,128,168.67. Following the sale, the chief executive officer now directly owns 111,735 shares of the company’s stock, valued at $18,417,280.05. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Dawn C. Willoughby sold 25,950 shares of the firm’s stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $164.59, for a total value of $4,271,110.50. Following the completion of the sale, the chief operating officer now directly owns 32,409 shares in the company, valued at $5,334,197.31. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 236,361 shares of company stock worth $38,700,029. 1.40% of the stock is currently owned by company insiders.

Clorox stock opened at $155.28 on Thursday. The company has a debt-to-equity ratio of 3.08, a quick ratio of 0.66 and a current ratio of 1.15. The firm has a market cap of $19.99 billion, a price-to-earnings ratio of 24.81, a price-to-earnings-growth ratio of 3.87 and a beta of 0.29. Clorox Co has a one year low of $113.57 and a one year high of $167.70.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 4th. The company reported $1.40 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.32 by $0.08. The firm had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.77 earnings per share. On average, sell-side analysts predict that Clorox Co will post 6.33 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a $0.96 dividend. This represents a $3.84 annualized dividend and a dividend yield of 2.47%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 61.34%.

TRADEMARK VIOLATION WARNING: This report was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://www.com-unik.info/2019/02/21/clorox-co-clx-shares-bought-by-piedmont-investment-advisors-inc.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Terms to Better Understand Call Options

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit